Chemoinformaics analysis of 8-hydroxypinoresinol
| Molecular Weight | 374.389 | nRot | 4 |
| Heavy Atom Molecular Weight | 352.213 | nRig | 21 |
| Exact Molecular Weight | 374.137 | nRing | 4 |
| Solubility: LogS | -3.46 | nHRing | 2 |
| Solubility: LogP | 1.815 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 12 |
| nHA | 7 | APOL | 53.6834 |
| nHD | 3 | BPOL | 29.0146 |
| QED | 0.755 |
| Synth | 3.882 |
| Natural Product Likeliness | 1.689 |
| NR-PPAR-gamma | 0.784 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.128 |
| HIA | 0.028 |
| CACO-2 | -4.951 |
| MDCK | 0.00000988 |
| BBB | 0.14 |
| PPB | 0.943981 |
| VDSS | 1.15 |
| FU | 0.0722844 |
| CYP1A2-inh | 0.038 |
| CYP1A2-sub | 0.883 |
| CYP2c19-inh | 0.039 |
| CYP2c19-sub | 0.691 |
| CYP2c9-inh | 0.111 |
| CYP2c9-sub | 0.696 |
| CYP2d6-inh | 0.174 |
| CYP2d6-sub | 0.851 |
| CYP3a4-inh | 0.468 |
| CYP3a4-sub | 0.366 |
| CL | 12.746 |
| T12 | 0.482 |
| hERG | 0.031 |
| Ames | 0.739 |
| ROA | 0.529 |
| SkinSen | 0.904 |
| Carcinogencity | 0.221 |
| EI | 0.343 |
| Respiratory | 0.364 |
| NR-Aromatase | 0.894 |
| Antiviral | No |
| Prediction | 0.54947 |